193
Views
5
CrossRef citations to date
0
Altmetric
Articles

Trends and risk factors in the antibiotic management of skin and soft tissue infections in the United States

, , & ORCID Icon
Pages 1576-1580 | Received 15 Oct 2020, Accepted 14 Nov 2020, Published online: 28 Jan 2021

References

  • Carleton HA, Diep BA, Charlebois ED, et al. Community-adapted methicillin‐resistant Staphylococcus aureus (MRSA): population dynamics of an expanding community reservoir of MRSA. J Infect Dis. 2004;190(10):1730–1738.
  • Khan A, Wilson B, Gould IM. Current and future treatment options for community-associated MRSA infection. Expert Opin Pharmacother. 2018;19(5):457–470.
  • Meddles-Torres C, Hu S, Jurgens C. Changes in prescriptive practices in skin and soft tissue infections associated with the increased occurrence of community acquired methicillin resistant Staphylococcus aureus. J Infect Public Health. 2013;6(6):423–430.
  • Hersh AL, Chambers HF, Maselli JH, et al. National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Arch Intern Med. 2008;168(14):1585–1591.
  • Dobson EL, Klepser ME, Pogue JM, et al. Outpatient antibiotic stewardship: interventions and opportunities. J Am Pharm Assoc. 2017;57(4):464–473.
  • Klepser ME, Dobson EL, Pogue JM, et al. A call to action for outpatient antibiotic stewardship. J Am Pharm Assoc. 2017;57(4):457–463.
  • Cole KA, Rivard KR, Dumkow LE. Antimicrobial stewardship interventions to combat antibiotic resistance: an update on targeted strategies. Curr Infect Dis Rep. 2019;21(10):33.
  • Pallin DJ, Egan DJ, Pelletier AJ, et al. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus. Ann Emerg Med. 2008;51(3):291–298.
  • Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52(3):e18–55–e55.
  • Bassetti M, Righi E, Carnelutti A. New therapeutic options for skin and soft tissue infections. Curr Opin Infect Dis. 2016;29(2):99–108.
  • Wetzel M, Fleischer A. Factors affecting the rise of treatment of resistant bacteria in skin and soft tissue infections in the United States: 1993-2012. J Dermatolog Treat. 2017;28:417–421.
  • Ibrahim F, Khan T, Pujalte G. Bacterial skin infections. Prim Care. 2015;42:485–499.
  • Lee A, de Lencastre H, Garau J, et al. Methicillin-resistant Staphylococcus aureus. Nat Rev Dis Prim. 2018;4:18033.
  • Andersson D, Hughes D. Antibiotic resistance and its cost: is it possible to reverse resistance? Nat Rev Microbiol. 2010;8(4):260–271.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.